Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 2/2012

01-04-2012 | Short Research Report

Acceptance and importance of clinical pharmacists’ LIMM-based recommendations

Authors: Åsa Bondesson, Lydia Holmdahl, Patrik Midlöv, Peter Höglund, Emmy Andersson, Tommy Eriksson

Published in: International Journal of Clinical Pharmacy | Issue 2/2012

Login to get access

Abstract

Objective The objective of this study was to evaluate the quality of the clinical pharmacy service in a Swedish hospital according to the Lund Integrated Medicine Management (LIMM) model, in terms of the acceptance and clinical significance of the recommendations made by clinical pharmacists. Method The clinical significance of the recommendations made by clinical pharmacists was assessed for a random sample of inpatients receiving the clinical pharmacy service in 2007. Two independent physicians retrospectively ranked the recommendations emerging from errors in the patients’ current medication list and actual drug-related problems according to Hatoum, with rankings ranging between 1 (adverse significance) and 6 (extremely significant). Results The random sample comprised 132 patients (out of 800 receiving the service). The clinical significance of 197 recommendations was assessed. The physicians accepted and implemented 178 (90%) of the clinical pharmacists’ recommendations. Most of these recommendations, 170 (83%), were ranked 3 (somewhat significant) or higher. Conclusion This study provides further evidence of the quality of the LIMM model and confirms that the inclusion of clinical pharmacists in a multi-professional team can improve drug therapy for inpatients. The very high level of acceptance by the physicians of the pharmacists’ recommendations further demonstrates the effectiveness of the process.
Literature
1.
go back to reference Hellstrom LM, Bondesson A, Hoglund P, Midlov P, Holmdahl L, Rickhag E, et al. Impact of the Lund Integrated Medicines Management (LIMM) model on medication appropriateness and drug-related hospital revisits. Eur J Clin Pharmacol. 2011;67(7):741–52. doi:10.1007/s00228-010-0982-3.PubMedCrossRef Hellstrom LM, Bondesson A, Hoglund P, Midlov P, Holmdahl L, Rickhag E, et al. Impact of the Lund Integrated Medicines Management (LIMM) model on medication appropriateness and drug-related hospital revisits. Eur J Clin Pharmacol. 2011;67(7):741–52. doi:10.​1007/​s00228-010-0982-3.PubMedCrossRef
3.
go back to reference Hatoum HT, Hutchinson RA, Witte KW, Newby GP. Evaluation of the contribution of clinical pharmacists: inpatient care and cost reduction. Drug Intell Clin Pharm. 1988;22:252–9.PubMed Hatoum HT, Hutchinson RA, Witte KW, Newby GP. Evaluation of the contribution of clinical pharmacists: inpatient care and cost reduction. Drug Intell Clin Pharm. 1988;22:252–9.PubMed
5.
go back to reference Overhage JM, Lukes A. Practical, reliable, comprehensive method for characterizing pharmacists’ clinical activities. Am J Health Syst Pharm. 1999;56:2444–50.PubMed Overhage JM, Lukes A. Practical, reliable, comprehensive method for characterizing pharmacists’ clinical activities. Am J Health Syst Pharm. 1999;56:2444–50.PubMed
7.
go back to reference Sorensen L, Grobler MP, Roberts MS. Development of a quality use of medicines coding system to rate clinical pharmacists’ medication review recommendations. Pharm World Sci. 2003;25:212–7.PubMedCrossRef Sorensen L, Grobler MP, Roberts MS. Development of a quality use of medicines coding system to rate clinical pharmacists’ medication review recommendations. Pharm World Sci. 2003;25:212–7.PubMedCrossRef
8.
go back to reference Cipolle RJ, Strand LM, Morley PC. Pharmaceutical care practice. New York: The McGraw-Hill Companies Inc; 1998. Cipolle RJ, Strand LM, Morley PC. Pharmaceutical care practice. New York: The McGraw-Hill Companies Inc; 1998.
Metadata
Title
Acceptance and importance of clinical pharmacists’ LIMM-based recommendations
Authors
Åsa Bondesson
Lydia Holmdahl
Patrik Midlöv
Peter Höglund
Emmy Andersson
Tommy Eriksson
Publication date
01-04-2012
Publisher
Springer Netherlands
Published in
International Journal of Clinical Pharmacy / Issue 2/2012
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-012-9609-3

Other articles of this Issue 2/2012

International Journal of Clinical Pharmacy 2/2012 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.